Observational studyJournal of hematology & oncology2026
Outcomes of front-line tagraxofusp in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) in a real-world scenario.
Jan C Schroeder et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.